Darunavir and Cobicistat is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Darunavir/cobicistat fixed dose combination is indicated, in combination with other antiretroviral medicinal products, for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg).
Genotypic testing should guide the use of darunavir/cobicistat.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Darunavir and Cobicistat is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.